Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
NOVO_BNOVO NORDISK B A/S | 4.061 T DKK | 915.7 DKK | −0.43% | 2.086 M | 0.80 | 45.99 | 19.91 DKK | +47.53% | 1.02% | Health Technology | Buy |
GMABGENMAB A/S | 127.357 B DKK | 1934.5 DKK | −1.05% | 118.736 K | 0.80 | 23.37 | 82.78 DKK | +3.37% | 0.00% | Health Technology | Buy |
ZEALZEALAND PHARMA A/S | 38.24 B DKK | 614.5 DKK | −0.41% | 237.079 K | 0.76 | — | −12.52 DKK | +46.15% | 0.00% | Health Technology | Strong buy |
HLUN_AH. LUNDBECK A/S A | 29.499 B DKK | 32.40 DKK | −0.15% | 50.539 K | 0.30 | 13.31 | 2.43 DKK | +1.46% | 2.16% | Health Technology | — |
HLUN_BH. LUNDBECK A/S B | 29.499 B DKK | 37.14 DKK | +0.43% | 351.6 K | 0.45 | 15.26 | 2.43 DKK | +1.46% | 1.89% | Health Technology | Neutral |
BAVABAVARIAN NORDIC A/S | 13.882 B DKK | 177.95 DKK | −0.73% | 292.689 K | 0.56 | 13.88 | 12.82 DKK | +241.38% | 0.00% | Health Technology | Buy |
ORPHAORPHAZYME A/S | 35.806 M DKK | 1014.0 DKK | −0.08% | 21 | 0.40 | — | −737.65 DKK | +95.89% | 0.00% | Health Technology | — |